Zobrazeno 1 - 10
of 406
pro vyhledávání: '"Isin EM"'
Autor:
van der Vloet L; The Maastricht MultiModal Molecular Imaging (M4I) institute, Division of Imaging Mass Spectrometry (IMS), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands., Hilaire PBS; Institut de Recherche et Développement Servier Paris-Saclay, Rue Francis Perrin, 91190 Gif-sur-Yvette, France., Bouillod C; Institut de Recherche et Développement Servier Paris-Saclay, Rue Francis Perrin, 91190 Gif-sur-Yvette, France., Isin EM; Institut de Recherche et Développement Servier Paris-Saclay, Rue Francis Perrin, 91190 Gif-sur-Yvette, France., Heeren RMA; The Maastricht MultiModal Molecular Imaging (M4I) institute, Division of Imaging Mass Spectrometry (IMS), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands. Electronic address: r.heeren@maastrichtuniversity.nl., Vandenbosch M; The Maastricht MultiModal Molecular Imaging (M4I) institute, Division of Imaging Mass Spectrometry (IMS), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Dec 17; Vol. 30 (1), pp. 104275. Date of Electronic Publication: 2024 Dec 17.
Autor:
Walles M; Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland., Pähler A; Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland., Isin EM; DMPK, Translational Medicine, Servier, Paris-Saclay, France., Ahlqvist MM; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2024 Sep; Vol. 54 (9), pp. 770-775. Date of Electronic Publication: 2024 Sep 18.
Autor:
Walles M; Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland., Pähler A; F Hoffmann-La Roche AG Research and Development Division, Pharma Research and Early Development, Basel, Switzerland., Isin EM; DMPK, Translational Medicine, Paris-Saclay, France., Ahlqvist MM; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2024 May; Vol. 54 (5), pp. 257-262. Date of Electronic Publication: 2024 Jan 17.
Autor:
Isin EM; Translational Medicine, Servier, 25/27 Rue Eugène Vignat, 45000, Orléans, France Emre.Isin@servier.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2023 Apr; Vol. 51 (4), pp. 413-426. Date of Electronic Publication: 2023 Jan 18.
Autor:
Walles M; Department of Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland., Pähler A; F Hoffmann-La Roche AG Research and Development Division, Pharma Research and Early Development, Basel, Switzerland., Isin EM; Les Laboratoires Servier SAS Recherche and Developpement, DMPK, Translational Medicine, Servier, France., Ahlqvist MM; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2023 Feb; Vol. 53 (2), pp. 123-127. Date of Electronic Publication: 2023 Jan 31.
Autor:
Vermeulen I; The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands., Isin EM; Development Science, UCB Biopharma SRL, Chemin du Foriest, B1420 Braine-l'Alleud, Belgium., Barton P; DMPK, UCB Celltech, Branch of UCB Pharma SA, 208 Bath Road, Slough SL1 3WE, UK., Cillero-Pastor B; The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands., Heeren RMA; The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands. Electronic address: r.heeren@maastrichtuniversity.nl.
Publikováno v:
Drug discovery today [Drug Discov Today] 2022 Aug; Vol. 27 (8), pp. 2086-2099. Date of Electronic Publication: 2022 Apr 13.
Autor:
Cox B; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., Barton P; Development Science, UCB Biopharma SRL, 216 Bath Rd, Slough, Berkshire SL1 3WE, UK., Class R; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., Coxhead H; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., Delatour C; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., Gillent E; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., Henshall J; Development Science, UCB Biopharma SRL, 216 Bath Rd, Slough, Berkshire SL1 3WE, UK., Isin EM; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium., King L; Development Science, UCB Biopharma SRL, 216 Bath Rd, Slough, Berkshire SL1 3WE, UK., Valentin JP; Development Science, UCB Biopharma SRL, Chemin du Foriest 1, B1420 Braine-l'Alleud, Belgium.
Publikováno v:
Biomaterials and biosystems [Biomater Biosyst] 2022 May 30; Vol. 7, pp. 100054. Date of Electronic Publication: 2022 May 30 (Print Publication: 2022).
Autor:
Walles M; Department, a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland., Pähler A; Pharma Research and Early Development, Basel, Switzerland., Isin EM; DMPK, Translational Medicine, Orléans, France., Weidolf L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2022 Apr; Vol. 52 (4), pp. 426-431. Date of Electronic Publication: 2022 Apr 20.
Autor:
Walles M; Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland., Pähler A; pRED, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Weidolf L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Isin EM; DMPK, Translational Medicine, Servier, France.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2021 Sep; Vol. 51 (9), pp. 1081-1086. Date of Electronic Publication: 2021 Jul 29.
Autor:
Lindmark B; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Lundahl A; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Kanebratt KP; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Andersson TB; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Isin EM; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2018 Jun; Vol. 175 (11), pp. 2116-2129. Date of Electronic Publication: 2018 Apr 19.